The Immune Adjuvant Properties of Front-line Carboplatin-Paclitaxel: A Randomized Phase 2 Study of Alternative Schedules of Intravenous Oregovomab Chemoimmunotherapy in Advanced Ovarian Cancer

2009 ◽  
Vol 32 (1) ◽  
pp. 54-65 ◽  
Author(s):  
Patricia Braly ◽  
Christopher F. Nicodemus ◽  
Christina Chu ◽  
Yvonne Collins ◽  
Robert Edwards ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Advanced Ovarian Cancer ◽  
Phase 2 ◽  
Front Line ◽  
Phase 2 Study ◽  
Immune Adjuvant ◽  
Randomized Phase 2 ◽  
Alternative Schedules

scholarly journals A phase 2 study of intraperitoneal carboplatin plus intravenous dose-dense paclitaxel in front-line treatment of suboptimal residual ovarian cancer

2020 ◽  
Vol 122 (6) ◽  
pp. 766-770 ◽  
Author(s):  
Kosei Hasegawa ◽  
Muneaki Shimada ◽  
Satoshi Takeuchi ◽  
Hiroyuki Fujiwara ◽  
Yuichi Imai ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Intravenous Dose ◽  
Line Treatment ◽  
Phase 2 ◽  
Front Line ◽  
Phase 2 Study ◽  
Dose Dense

scholarly journals A Phase 2 study of cisplatin analog CI-973 in the treatment of patients with refractory, advanced ovarian cancer

1996 ◽  
Vol 6 (4) ◽  
pp. 257-260
Author(s):  
J.A. Roberts ◽  
A.P. Kudelka ◽  
D.R. Spriggs ◽  
F. Muggia ◽  
J. Lurain ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Advanced Ovarian Cancer ◽  
Phase 2 ◽  
Phase 2 Study ◽  
Cisplatin Analog

scholarly journals ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease

Nature Aging ◽  
2021 ◽  
Vol 1 (6) ◽  
pp. 521-534
Author(s):  
Petr Novak ◽  
Branislav Kovacech ◽  
Stanislav Katina ◽  
Reinhold Schmidt ◽  
Philip Scheltens ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Active Immunotherapy ◽  
Phase 2 ◽  
Phase 2 Study ◽  
Randomized Phase 2

scholarly journals Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study

2014 ◽  
Vol 15 (11) ◽  
pp. 1207-1214 ◽  
Author(s):  
Joyce F Liu ◽  
William T Barry ◽  
Michael Birrer ◽  
Jung-Min Lee ◽  
Ronald J Buckanovich ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase 2 ◽  
Platinum Sensitive ◽  
Phase 2 Study
Sign in / Sign up

Export Citation Format

Share Document